STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma’s anti-psychosis drug
The drug maker has run four randomized, placebo-controlled Phase 3 clinical trials of Nuplazid. Three of them have now failed
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario